方法证据记录
EASI
The EASI is a structured, clinician-administered tool for assessing the extent and intensity of atopic dermatitis across the body. Developed by Hanifin and colleagues in 2001, it divides the body into four regions with weighted area factors, ensuring proportional contribution to total score. EASI has become the primary objective severity measure in atopic dermatitis clinical trials and is recommended by international regulatory authorities (FDA, EMA).
源记录
引文逐字复制自方法源记录。这些引文不代表任何层级的验证。
Eczema Area and Severity Index
分类方法记录 · process-pipeline / dermatology
- Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 2001;10(1):11-18. · DOI 10.1034/j.1600-0625.2001.100102.x
- Stalder JF, Taïeb A. Therapeutic classification of atopic dermatitis. Arch Dermatol. 2003;139(9):1221-1222. · URL
精选声明
声明已持久化到证据分类账中，每个声明都有自己的评估。
尚无精选声明
当分类账中没有声明时，此视图不会自行创建声明评估。
相关方法
从方法图中生成，显示为机器建议的关系 — 不推断任何证据声明。